Targeted and Chemotherapeutic Approaches to
mCRC Management


Provided by

American Academy of CME, Inc.

Support for this activity has been made possible through educational grants from Celgene, Amgen and Takeda Oncology.

Release date:
Feb 26, 2018
Expiration date:
Feb 26, 2019
Estimated time to complete:
1.0 hours

Education Need

Oncology nurses play an extremely vital role on the interprofessional team managing patients with mCRC. These nurses frequently assume front-line functions in preparing patients for therapy, recognizing treatment-related toxicities and symptoms, and managing these complications while educating patients about their treatments and related side effects. As the treatment landscape for mCRC continues to evolve with new therapies, treatment regimens, and guideline recommendations, it is imperative that oncology nurses be educated on the latest developments in the field and be able to apply this knowledge to their roles in managing patients with mCRC and assist their fellow clinicians in improving patient outcomes and quality of life.

Activity Faculty

Nicole Ross

Nicole M. Ross, MSN, CRNP, AOCNP  
Advanced Practice Clinician
Advanced Oncology Certified Nurse
Practitioner, Dept. of Hematology/Oncology
Fox Chase Cancer Center
Dept. of Medicine, Section

Target Audience

This activity has been designed to meet the educational needs of oncology nursing professionals involved with the care of patients with metastatic colorectal cancer.

Learning Objective/Learning Outcomes

After participating in this activity, learners should be better able to:

  1. Critically evaluate current clinical trial evidence supporting the use of targeted and chemotherapeutic approaches, and their combinations, in the management of metastatic colorectal cancer (mCRC) across multiple lines of treatment.

  2. Explain which factors driving patientsí segmentation (prognostic and predictive biomarkers, comorbidities, patientsí preference) impact the treatment decision-making process in different clinical scenarios across disease progression

  3. Review current best practices for the management of adverse effects associated with targeted therapies in mCRC and how to maximize tolerability and adherence to different therapeutic regimens

  4. Employ communication strategies that will help convey the benefits and burdens of clinical trials

Accreditation and Credit Designation
American Academy of CME, Inc, is accredited as a provider of continuing nursing education by the American Nurses Credentialing Centerís Commission on Accreditation.

American Academy of CME, Inc., designates this educational activity for 1.0 contact hours. (0.9 pharmacotherapeutic contact hours)

Disclosure Statement
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.

Faculty Disclosure
Ms. Ross discloses the following:
Other Relationship: Presenter on Medscape Activity "The Nurse View: Updates in Management of Metastatic Colorectal Cancer"

This educational activity may contain discussion of published and/or investigational uses of agents not indicated by the FDA. Faculty have been asked to disclose off-label and/or investigational uses if they are mentioned. Please refer to official prescribing information for each product for discussion of approved indications, contraindications, and warnings. American Academy of CME requires faculty to provide the level of evidence for patient care recommendation made during their presentations.

Planning Committee
John JD Juchniewicz, MCIS, CCMEP, Natalie Kirkwood, RN, BSN, JD, Lead Nurse Planner, Paul Minter, MS, and Wendy Gloffke, PhD - American Academy of CME: No relevant financial relationships with any commercial interests.

The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy, or American Nurses Credentialing Centerís Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information. 

Method of Participation
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives/learning outcomes and disclosure statements, as well as the content of the activity. To receive CNE credit for your participation, please complete the post-test (achieving a passing grade of 70% or greater), and program evaluation

Your certificate can be printed immediately.

Hardware/Software Requirements
This program should be viewed at a resolution of 1024 x 768 or higher using current versions of Microsoft Internet Explorer, Firefox, Chrome or Safari. A high-speed Internet connection is recommended.

For more information about the American Academy of CME, Inc. privacy policy, please access

For any questions, please contact:


©2018. This CNE-certified activity is held as copyrighted ©by American Academy of CME, Inc. Through this notice, the Academy  grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

Proceed to Activity